Research

A collection of the latest research and findings in the respiratory space

Research

Filter by topic:

All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Breast and Lung Effusion Survival Score Models:

Sofia Molina, MD Gabriela Martinez-Zayas, MD Paula V. Sainz, MS Cheuk H. Leung, MS Liang Li, PhD Horiana B. Grosu, MD, MPH Roberto Adachi, MD David E. Ost, MD, MPH

11 April, 2021

NZ Respiratory Research Review Issue 193

Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients:

Jennifer A. Bartell, Lea M. Sommer, Rasmus L. Marvig, Marianne Skov, Tacjana Pressler, Søren Molin, Helle Krogh Johansen

8 April, 2021

NZ Respiratory Research Review Issue 191

Longitudinal monitoring of asthma in the clinic using respiratory oscillometry:

Alice M. Cottee,Leigh M. Seccombe,Cindy Thamrin,Tanya Badal,Gregory G. King,Matthew J. Peters,Claude S. Farah,

1 April, 2021

NZ Respiratory Research Review Issue 188

Long-term prognosis of new adult-onset asthma in obese patients:

Pinja Ilmarinen, Adrienn Pardo, Leena E. Tuomisto, Iida Vähätalo, Onni Niemelä, Pentti Nieminen, Hannu Kankaanranta

1 April, 2021

NZ Respiratory Research Review Issue 188

Sotatercept for the Treatment of Pulmonary Arterial Hypertension:

Marc Humbert, M.D., Ph.D., Vallerie McLaughlin, M.D., J. Simon R. Gibbs, M.D., Mardi Gomberg-Maitland, M.D., Marius M. Hoeper, M.D., Ioana R. Preston, M.D., Rogerio Souza, M.D., Ph.D., Aaron Waxman, M.D., Ph.D., Pilar Escribano Subias, M.D., Ph.D., Jeremy Feldman, M.D., Gisela Meyer, M.D., David Montani, M.D., Ph.D., et al., for the PULSAR Trial Investigators

1 April, 2021

NZ Respiratory Research Review Issue 190

Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study:

Carey M Suehs, Andrew Menzies-Gow, David Price, Eugene R. Bleecker, Giorgio Walter Canonica, Mark Gurnell and Arnaud Bourdin

1 April, 2021

NZ Respiratory Research Review Issue 194

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial:

Prof Jürgen Behr, MD Prof Antje Prasse, MD Prof Michael Kreuter, MD Johannes Johow, PhD Prof Klaus F Rabe, MD Prof Francesco Bonella, MD et al.

30 March, 2021

NZ Respiratory Research Review Issue 189

Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data:

Syed A Shah, Jennifer K Quint, Bright I Nwaru, Aziz Sheikh

29 March, 2021

NZ Respiratory Research Review Issue 194

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort:

Bartolome Celli, Nicholas Locantore, Julie C. Yates, Per Bakke, Peter M.A. Calverley, Courtney Crim, Harvey O. Coxson, David A. Lomas, William MacNee, Bruce E. Miller , Hana Mullerova , Stephen I. Rennard , Edwin K. Silverman , Emiel Wouters, Ruth Tal-Singer , Alvar Agusti and Jørgen Vestbo for the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators

25 March, 2021

NZ Respiratory Research Review Issue 186

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial:

Prof Marius M Hoeper, MD Prof Hikmet Al-Hiti, MD Prof Raymond L Benza, MD Prof Sung-A Chang, MD Prof Paul A Corris, MD J Simon R Gibbs, MD et al.

24 March, 2021

NZ Respiratory Research Review Issue 190